Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-24 Purchase |
2024-01-26 5:40 pm |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
280,000 | $0.4996 | $139,888 | 1,375,425 (Direct) |
View |
| 2023-12-15 Purchase |
2023-12-19 7:09 pm |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
595,425 | $0.31698 | $188,737 | 1,095,425 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-05 4:29 pm |
N/A 2035-03-03 |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 4:07 pm |
N/A 2034-06-20 |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-12-12 Option Award |
2023-12-14 6:44 pm |
N/A 2033-12-12 |
Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer |
1,477,619 | $0 | 2,885,688 (Direct) |
View |
Ownership |
2023-02-13 4:32 pm |
N/A N/A |
Isoray Inc. | ISR | Puhlmann Markus Chief Medical Officer |
0 | $0 | 1,908,069 (Direct) |
View |